Mobile Menu

Search Results

Search results for: Pharma

Genomics against COVID-19: A summary

Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]

The potential role of PGx in managing experimental therapies for COVID-19

Since the outbreak of the COVID-19 pandemic, many clinical trials have been launched to help understand the virus and any […]

Genetics Unzipped Podcast: Involving Patients in Genomics Research

“Nothing about me without me!” is the rallying cry for patient involvement in research. In the latest episode of Genetics […]

Continuomics and the future of clinical trials

“No decision about me, without me” was to be the new standard of thinking for a more patient-centric NHS future, […]

Direct to consumer genetics – Whose data is it?

Many pharmaceutical companies are switching their focus to collecting, analysing and learning from large data sets. In fact, in early […]

Partner with Us

*** To request our Media Kit or to find out more about partnering with us, email Beth or call her on […]

“Usually, you’re relatively alone in your rare disease community” – Interview with Shelley Simmonds, Patient Advocate for rare diseases

Shelley Simmonds is a patient advocate whose son has Duchenne muscular dystrophy. Duchenne causes muscle weakening and wasting and is […]

Interview with Dr Michelle Krishnan, Translational Medicine Leader in Rare Diseases, Roche

Dr Michelle Krishnan is the Translational Medicine Leading in Rare Diseases at Roche where she focuses on developing transformative therapies […]

FoG 2020 Presentation Michael Barnes, QMUL: RNA Sequencing and Machine Learning as Molecular Scalpels

Professor of Bioinformatics, Director, the Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London Co-Investigator, Health […]

FoG 2020 Presentation Christopher Smither, CRUK: Exploiting Cell-Free DNA in Blood for Improved Treatment of Cancer

Chris has studied cancer genetics for the best part of ten years. Previously he studied the genetics and pharmacogenetics of […]